Crossref
Apathy to the power of 3 — the government, judiciary, and pharma companies on patented drug pricing
Indian Journal of Medical Ethics · 11.11.2026 · 11 (4) · 261
DOI: 10.20529/ijme.2026.065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Medical Ethics, online erschienen am 11.11.2026. Verfasst von Prathibha Sivasubramanian und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sivasubramanian, P., Johari, V., & Mathews, K. M. (2026). Apathy to the power of 3 — the government, judiciary, and pharma companies on patented drug pricing. Indian Journal of Medical Ethics, 11(4), 261. https://doi.org/10.20529/ijme.2026.065
Vancouver
Sivasubramanian P, Johari V, Mathews KM. Apathy to the power of 3 — the government, judiciary, and pharma companies on patented drug pricing. Indian Journal of Medical Ethics. 2026;11(4):261. doi:10.20529/ijme.2026.065
BibTeX
@article{Sivasubramanian2026,
author = {Sivasubramanian, Prathibha and Johari, Veena and Mathews, Karunyapriya Maryam},
title = {Apathy to the power of 3 — the government, judiciary, and pharma companies on patented drug pricing},
journal = {Indian Journal of Medical Ethics},
year = {2026},
volume = {11},
number = {4},
pages = {261},
doi = {10.20529/ijme.2026.065}
}
EUVIMED